Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.217281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024. Verfasst von Daniel R Plaugher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA. Electronic address: plaugher_dr@uky.edu. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lymphocytes, Tumor-Infiltrating, Lung Neoplasms, Immunotherapy, Adoptive. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related death worldwide, with poor outcomes even for those diagnosed at early stages. Current standard-of-care for most non-small cell lung cancer (NSCLC) patients involves an array of chemotherapy, radiotherapy, immunotherapy, targeted therapy, and surgical resection depending on the stage and location of the cancer. While patient outcomes have certainly improved, advances in highly personalized care remain limited. However, there is growing excitement around harnessing the power of tumor-infiltrating lymphocytes (TILs) through the use of adoptive cell transfer (ACT) therapy. These TILs are naturally occurring, may already recognize tumor-specific antigens, and can have direct anti-cancer effect. In this review, we highlight comparisons of various ACTs, including a brief TIL history, show current advances and successes of TIL therapy in NSCLC, discuss the potential roles for epigenetics in T cell expansion, and highlight challenges and future directions of the field to combat NSCLC in a personalized manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA. Electronic address: plaugher_dr@uky.edu.
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA.
- Department of Internal Medicine - Medical Oncology, University of Kentucky, Lexington, KY, 40536, USA; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA.
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY, 40536, USA; Markey Cancer Center, University of Kentucky, Lexington, KY, 40536, USA. Electronic address: cfbrainson@uky.edu.
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- American Institute for Cancer Research
- Markey Cancer Center
Zitieren
APA
Plaugher, D. R., Childress, A. R., Gosser, C. M., Esoe, D. P., Naughton, K. J., Hao, Z., & Brainson, C. F. (2024). Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217281
Vancouver
Plaugher DR, Childress AR, Gosser CM, Esoe DP, Naughton KJ, Hao Z, et al. Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217281
BibTeX
@article{Plaugher2024,
author = {Plaugher, Daniel R and Childress, Avery R and Gosser, Christian M and Esoe, Dave-Preston and Naughton, Kassandra J and Hao, Zhonglin and Brainson, Christine F},
title = {Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.217281}
}
EUVIMED